Skip to main content
. 2017 Sep 27;8(17):3490–3497. doi: 10.7150/jca.19109

Figure 2.

Figure 2

Overall survival (OS) and progression-free survival (PFS) analysis of patients with bladder urothelial carcinoma based on ARID1B expression. Kaplan-Meier analysis of OS (A) and PFS (B).